Accelerate Diagnostics (AXDX) Short Interest Ratio & Short Volume $0.97 -0.07 (-6.83%) As of 03/25/2025 04:00 PM Eastern Add Compare Share Share Short Interest Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock Accelerate Diagnostics Short Interest DataAccelerate Diagnostics (AXDX) has a short interest of 439,600 shares, representing 2.88% of the float (the number of shares available for trading by the public). This marks a -1.19% decrease in short interest from the previous month. The short interest ratio (days to cover) is 8.5, indicating that it would take 8.5 days of the average trading volume of 60,277 shares to cover all short positions.Current Short Interest439,600 sharesPrevious Short Interest444,900 sharesChange Vs. Previous Month-1.19%Dollar Volume Sold Short$474,768.00Short Interest Ratio8.5 Days to CoverLast Record DateFebruary 28, 2025Outstanding Shares25,044,000 sharesFloat Size15,250,000 sharesShort Percent of Float2.88%Today's Trading Volume40,086 sharesAverage Trading Volume60,277 sharesToday's Volume Vs. Average67% Short Selling Accelerate Diagnostics? Sign up to receive the latest short interest report for Accelerate Diagnostics and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartAXDX Short Interest Over TimeAXDX Days to Cover Over TimeAXDX Percentage of Float Shorted Over Time Remove Ads Accelerate Diagnostics Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 2/28/2025439,600 shares $474,768.00 -1.2%2.9%8.5 $1.08 2/15/2025444,900 shares $524,982.00 -4.0%2.9%8.3 $1.18 1/31/2025463,600 shares $625,860.00 +15.4%3.0%8 $1.35 1/15/2025401,900 shares $454,106.81 -1.2%2.6%6.1 $1.13 12/31/2024406,600 shares $487,920.00 -17.6%2.7%6.1 $1.20 12/15/2024493,500 shares $646,485.00 -6.0%3.2%7.6 $1.31 11/30/2024525,000 shares $871,500.00 0.0%3.6%8.7 $1.66 11/15/2024525,200 shares $971,620.00 +2.9%3.6%8.3 $1.85 10/31/2024510,500 shares $980,160.00 +7.9%3.5%7.6 $1.92 10/15/2024473,100 shares $884,697.00 -0.8%3.4%7.7 $1.87 Get the Latest News and Ratings for AXDX and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Accelerate Diagnostics and its competitors with MarketBeat's FREE daily newsletter. 9/30/2024476,700 shares $815,157.00 +1.8%3.4%8.3 $1.71 9/15/2024468,400 shares $711,968.00 -12.6%3.4%8.9 $1.52 8/31/2024535,700 shares $1.07 million -2.8%3.9%10 $2.00 8/15/2024551,100 shares $920,337.00 -8.0%4.2%8.4 $1.67 7/31/2024599,300 shares $809,055.00 -1.4%4.9%8.7 $1.35 7/15/2024607,700 shares $698,855.00 -3.4%5.0%9.1 $1.15 6/30/2024629,000 shares $735,930.00 +14.0%5.2%9.1 $1.17 6/15/2024551,700 shares $744,795.00 +30.0%4.5%7.1 $1.35 5/31/2024424,400 shares $505,036.00 +9.6%3.5%5.6 $1.19 5/15/2024387,300 shares $356,316.00 +19.9%2.8%5.3 $0.92 4/30/2024322,900 shares $284,668.64 -13.6%2.5%5.2 $0.88 4/15/2024373,700 shares $326,987.50 +27.7%2.9%4.3 $0.88 3/31/2024292,600 shares $289,674.00 +1.7%2.3%2.2 $0.99 3/15/2024287,600 shares $273,220.00 -3.8%2.4%2.4 $0.95 2/29/2024299,000 shares $294,544.90 -13.9%2.5%2.5 $0.99 2/15/2024347,300 shares $413,287.00 -7.2%2.9%3 $1.19 1/31/2024374,200 shares $497,686.00 -16.5%4.2%3.4 $1.33 1/15/2024448,300 shares $1.66 million +9.9%5.8%5.3 $3.70 12/31/2023407,800 shares $1.60 million +3.6%5.3%14.1 $3.92 12/15/2023393,500 shares $1.81 million -10.0%5.1%13.9 $4.61 11/30/2023437,300 shares $1.89 million +11.9%5.8%17.6 $4.32 11/15/2023390,900 shares $2.07 million -2.4%5.2%23.1 $5.29 10/31/2023400,500 shares $2.40 million +11.8%5.4%23 $5.99 10/15/2023358,100 shares $2.11 million +11.5%4.8%17.9 $5.88 9/30/2023321,300 shares $1.85 million -8.9%4.3%13 $5.75 9/15/2023352,600 shares $2.16 million -15.2%4.7%15.3 $6.14 8/31/2023415,800 shares $2.91 million -1.2%9.3%15.6 $7.01 8/15/2023420,900 shares $2.98 million -3.8%9.4%15.1 $7.09 7/31/2023437,400 shares $2.91 million +8.4%14.1%15.9 $6.66 7/15/2023403,500 shares $2.80 million +3.5%13.0%14.6 $6.95New “Trump” currency proposed in DC (Ad)According to one of the most connected men in Washington… A surprising new bill was just introduced in Washington. Its purpose: to put Donald Trump’s face on the $100 note. All to celebrate a new “golden age” for America. When you see what could happen – I think you’ll be excited. 6/30/2023390,000 shares $3.16 million -90.3%12.5%16.3 $8.10 6/15/20234,000,000 shares $3.17 million -7.6%12.9%14.9 $0.79 5/31/20234,330,000 shares $3.03 million +6.7%N/A16.7 $0.70 5/15/20234,060,000 shares $3.25 million -6.0%N/A13.4 $0.80 4/30/20234,320,000 shares $3.81 million -11.1%N/A14 $0.88 4/15/20234,860,000 shares $3.21 million +2.1%N/A16 $0.66 3/31/20234,760,000 shares $3.33 million -6.1%N/A16.2 $0.70 3/15/20235,070,000 shares $2.74 million +7.2%N/A16.6 $0.54 2/28/20234,730,000 shares $2.41 million +5.1%N/A15 $0.51 2/15/20234,500,000 shares $2.70 million +0.5%N/A15.5 $0.60 1/31/20234,480,000 shares $3.11 million +0.5%N/A15.8 $0.69 1/15/20234,460,000 shares $3.21 million -0.7%N/A13.3 $0.72 12/30/20224,490,000 shares $3.17 million +3.7%N/A13.6 $0.71 12/15/20224,330,000 shares $2.94 million -0.2%N/A14.6 $0.68 11/30/20224,340,000 shares $3.77 million +10.7%N/A12.8 $0.87 11/15/20223,920,000 shares $4.78 million -1.3%N/A8.4 $1.22 10/31/20223,970,000 shares $5.04 million -17.6%N/A4.3 $1.27 10/15/20224,820,000 shares $7.42 million -1.8%N/A5.1 $1.54 9/30/20224,910,000 shares $7.46 million -3.0%N/A5.3 $1.52 9/15/20225,060,000 shares $8.30 million -1.8%N/A4.6 $1.64 8/31/20225,150,000 shares $8.39 million -8.9%N/A4.1 $1.63 8/15/20225,650,000 shares $15.14 million +4.4%N/A3.9 $2.68 7/31/20225,410,000 shares $7.25 million +5.3%10.6%5.2 $1.34 7/15/20225,140,000 shares $7.30 million +5.3%10.1%4.7 $1.42 6/30/20224,880,000 shares $4.84 million -27.5%9.6%4.3 $0.99 6/15/20226,730,000 shares $6.25 million -3.4%13.2%5.9 $0.93 5/31/20226,970,000 shares $4.24 million +3.6%13.6%7.7 $0.61 5/15/20226,730,000 shares $4.64 million +0.3%14.3%12.7 $0.69 4/30/20226,710,000 shares $6.44 million -5.0%16.2%14.6 $0.96 4/15/20227,060,000 shares $7.27 million No Change17.0%17.1 $1.03 3/31/20227,060,000 shares $10.17 million +1.3%17.0%19.8 $1.44 3/15/20226,970,000 shares $11.85 million +1.5%17.3%22 $1.70 2/28/20226,870,000 shares $19.51 million -3.8%16.6%20.6 $2.84 2/15/20227,140,000 shares $20.13 million +2.0%17.3%18.7 $2.82 1/31/20227,000,000 shares $23.31 million +6.7%17.7%16.2 $3.33 1/15/20226,560,000 shares $26.90 million -1.4%16.5%15.7 $4.10 12/31/20216,650,000 shares $34.71 million -4.6%17.6%15.5 $5.22 12/15/20216,970,000 shares $31.64 million -2.7%18.5%15.2 $4.54 11/30/20217,160,000 shares $35.80 million -0.1%19.8%18 $5.00 11/15/20217,170,000 shares $47.97 million No Change19.1%21.8 $6.69 10/29/20217,170,000 shares $42.30 million -4.5%20.4%26.2 $5.90 10/15/20217,510,000 shares $49.79 million +0.8%21.4%29.8 $6.63 9/30/20217,450,000 shares $43.43 million -3.4%21.2%36.2 $5.83 9/15/20217,710,000 shares $46.11 million -2.4%22.5%49.5 $5.98 8/31/20217,900,000 shares $49.38 million -2.0%23.2%49.9 $6.25 8/13/20218,060,000 shares $48.12 million +0.1%23.6%47.6 $5.97 7/30/20218,050,000 shares $60.05 million +2.7%23.8%47.7 $7.46 7/15/20217,840,000 shares $51.35 million +0.9%23.2%42.7 $6.55 6/30/20217,770,000 shares $62.63 million -2.0%23.0%41.2 $8.06 6/15/20217,930,000 shares $71.29 million -3.7%23.4%41.4 $8.99Musk’s real agenda in D.C. (Ad)In this urgent exposé, you’ll discover… How Elon and Donald Trump are quietly drawing a radical new map of America…Here’s the full story. 5/28/20218,230,000 shares $62.47 million +3.4%24.2%41.3 $7.59 5/14/20217,960,000 shares $54.21 million -8.2%23.4%35 $6.81 4/30/20218,670,000 shares $64.24 million -0.2%25.4%33.9 $7.41 4/15/20218,690,000 shares $70.22 million -1.1%25.4%15.8 $8.08 3/31/20218,790,000 shares $71.46 million -0.8%26.7%15.4 $8.13 3/15/20218,860,000 shares $79.65 million +1.0%27.8%14.9 $8.99 2/26/20218,770,000 shares $90.24 million -8.5%27.5%14.4 $10.29 2/12/20219,580,000 shares $139.01 million -10.6%30.0%15.7 $14.51 1/29/202110,710,000 shares $110.63 million -19.9%34.8%18.1 $10.33 1/15/202113,370,000 shares $117.39 million -2.8%44.9%30.8 $8.78 12/31/202013,760,000 shares $102.51 million +0.2%46.3%52 $7.45 12/15/202013,740,000 shares $99.75 million -4.5%46.2%55.2 $7.26 11/30/202014,380,000 shares $116.77 million -3.4%48.3%56.4 $8.12 11/15/202014,880,000 shares $127.82 million -4.2%50.6%62 $8.59 10/30/202015,530,000 shares $147.22 million -0.6%52.8%57.8 $9.48 10/15/202015,630,000 shares $178.65 million -0.3%53.8%53.9 $11.43 9/30/202015,670,000 shares $167.04 million +5.0%53.9%49.3 $10.66 9/15/202014,920,000 shares $160.69 million +0.5%51.3%37.1 $10.77 8/31/202014,850,000 shares $180.87 million -3.3%51.1%31.5 $12.18 8/14/202015,350,000 shares $222.73 million -2.4%53.8%31.7 $14.51 7/31/202015,720,000 shares $228.41 million -0.3%55.1%34 $14.53 7/15/202015,760,000 shares $275.80 million -8.9%56.3%31.7 $17.50 6/30/202017,300,000 shares $249.99 million +1.7%61.8%33.8 $14.45 6/15/202017,010,000 shares $171.80 million +1.5%60.8%35.2 $10.10 5/29/202016,760,000 shares $140.78 million -0.3%55.1%34.6 $8.40 5/15/202016,810,000 shares $148.18 million +1.0%55.2%35.5 $8.82 4/30/202016,640,000 shares $181.54 million +5.5%52.9%37.2 $10.91 4/15/202015,780,000 shares $131.92 million +2.8%51.0%40.1 $8.36 3/31/202015,350,000 shares $157.80 million -0.6%51.4%41.9 $10.28 AXDX Short Interest - Frequently Asked Questions What is Accelerate Diagnostics' current short interest? Short interest is the volume of Accelerate Diagnostics shares that have been sold short but have not yet been covered or closed out. As of February 28th, traders have sold 439,600 shares of AXDX short. 2.88% of Accelerate Diagnostics' shares are currently sold short. Learn More on Accelerate Diagnostics' current short interest. What is a good short interest ratio for Accelerate Diagnostics? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. AXDX shares currently have a short interest ratio of 8.0. Learn More on Accelerate Diagnostics's short interest ratio. Which institutional investors are shorting Accelerate Diagnostics? As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of Accelerate Diagnostics: Concourse Financial Group Securities Inc., and Wolverine Asset Management LLC. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission. What is a good short interest percentage for Accelerate Diagnostics? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 2.88% of Accelerate Diagnostics' floating shares are currently sold short. Is Accelerate Diagnostics' short interest increasing or decreasing? Accelerate Diagnostics saw a decrease in short interest in February. As of February 28th, there was short interest totaling 439,600 shares, a decrease of 1.2% from the previous total of 444,900 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is Accelerate Diagnostics' float size? Accelerate Diagnostics currently has issued a total of 25,044,000 shares. Some of Accelerate Diagnostics' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Accelerate Diagnostics currently has a public float of 15,250,000 shares. How does Accelerate Diagnostics' short interest compare to its competitors? 2.88% of Accelerate Diagnostics' shares are currently sold short. Here is how the short interest of companies in the industry of "measuring and control equipment" compare to Accelerate Diagnostics: Akoya Biosciences, Inc. (17.43%), Owlet, Inc. (4.28%), Syntec Optics Holdings, Inc. (0.31%), Prenetics Global Limited (0.40%), Singular Genomics Systems, Inc. (2.91%), MultiSensor AI Holdings, Inc. (3.13%), Optex Systems Holdings, Inc (0.07%), ClearSign Technologies Co. (0.55%), Data I/O Co. (0.13%), Astrotech Co. (0.18%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: Invesco QQQ ($23.74 billion), iShares 20+ Year Treasury Bond ETF ($10.75 billion), MicroStrategy Incorporated ($6.56 billion), Apollo Global Management, Inc. ($5.40 billion), Charter Communications, Inc. ($4.57 billion), AppLovin Co. ($4.45 billion), Capital One Financial Co. ($4.33 billion), Super Micro Computer, Inc. ($4.23 billion), Schlumberger Limited ($3.22 billion), and Royal Caribbean Cruises Ltd. ($3.06 billion). View all of the most shorted stocks. What does it mean to sell short Accelerate Diagnostics stock? Short selling AXDX is an investing strategy that aims to generate trading profit from Accelerate Diagnostics as its price is falling. AXDX shares are trading down $0.07 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Accelerate Diagnostics? A short squeeze for Accelerate Diagnostics occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of AXDX, which in turn drives the price of the stock up even further. How often is Accelerate Diagnostics' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including AXDX, twice per month. The most recent reporting period available is February, 28 2025. More Short Interest Resources from MarketBeat Related Companies Akoya Biosciences Short Interest Data Owlet Short Interest Data Syntec Optics Short Interest Data Prenetics Global Short Interest Data Singular Genomics Systems Short Interest Data MultiSensor AI Short Interest Data Optex Systems Short Interest Data ClearSign Technologies Short Interest Data Data I/O Short Interest Data Astrotech Short Interest Data Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:AXDX) was last updated on 3/26/2025 by MarketBeat.com Staff From Our PartnersTrump’s Final Plan Presidential insider exposes shocking plot to reshape U.S. economy: The 2025 Trump Reset -- Inside Trump’...Porter & Company | SponsoredNew “Trump” currency proposed in DCAccording to one of the most connected men in Washington… A surprising new bill was just introduced in Wash...Paradigm Press | SponsoredDOGE could send 6 AI stocks through the roofStay alert for Elon Musk and the Department of Government Efficiency's next move … Expect an announcement f...Weiss Ratings | SponsoredTrump’s Secret WeaponHave you looked at the stock market recently? Millions of investors are scrambling trying to figure out what's...American Alternative | SponsoredNvidia’s CEO: “This Will Be a Multitrillion-Dollar Industry."If you missed out on the big boom in Nvidia… Listen up, because according to Nvidia's own CEO… Elon Musk...Brownstone Research | SponsoredThis Crypto Is Set to Explode in FebruaryBryce Paul believes this is the #1 coin to buy right now The catalyst behind this surge is a massive new b...Crypto 101 Media | SponsoredWhy Elon put $51 million into thisWhy Elon Musk Just Invested $51 Million Into Brand New “Miracle Metal” Developed by MIT ScientistsTrue Market Insiders | SponsoredURGENT: Someone's Moving Gold Out of London...People who don’t understand the gold market are about to lose a lot of money. Unfortunately, most so-called “g...Golden Portfolio | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Accelerate Diagnostics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Accelerate Diagnostics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
